Little is known about long-term health outcomes in phenotypic females with 46,XY disorders of sex development (XY females), and the socioeconomic profile has not been described in detail.
T he 46,XY disorder of sex development (DSD) affects approximately six phenotypic females per 100,000 newborn girls (we use the term "XY female" here). Androgen insensitivity syndrome (AIS) is most common, followed by gonadal dysgenesis (GD) and disorders of androgen synthesis (1) .
Because of the complexity of 46,XY DSD, treatment including sex hormone replacement, genital surgery, and gonadectomy may be required. The DSD condition itself, as well as its treatment, may affect the long-term health outcome in XY females, but the overall knowledge of this association is scarce. However, an increased risk for germ cell tumors (GCTs) is known. GCTs are most prevalent in XY females with GD in whom the prevalence is reported to range between 10% and 60% (2) (3) (4) (5) (6) . In prepubertal XY females with complete AIS (CAIS) the prevalence has been reported as low as 0.8% to 2% (2, 7) , whereas the prevalence of GCTs in postpubertal XY females recently has been reported to 10% (8) . The same authors (8) reported an almost similar prevalence (7%) of GCTs in partial AIS, which is considerably lower than previously thought (15% to 50%) (2, 7) .
Bone health is another concern in DSD as sex hormones play a pivotal role in bone development and maintenance of bone health (9) . Reduced bone mineral density is common in XY females (10) (11) (12) (13) . Most studies have been conducted in women with CAIS, although, because of endogenous estrogen production in women with AIS who have not undergone gonadectomy, women with GD may be more severely affected (14) . Appropriate sex hormone replacement is essential to ensure bone health and prevent osteoporosis in these women.
The DSD diagnosis may carry a stigma because of exposure to many diagnostic procedures and medical follow-up as well as concerns related to fertility, relationships, shame, and the taboo associated with the condition. The latter, however, may have improved during recent years as psychological support and openness have become a more integrated part of clinical management (7, 15) than previously (16) .
Other DSD conditions, such as Klinefelter and Turner syndromes, are associated with increased morbidity and mortality due to a wide range of diseases (17, 18) . In contrast, we recently reported a similar morbidity in phenotypic males with 46,XX DSD and the general population when we disregarded diagnoses closely associated to the DSD (19) . Overall, the socioeconomic profile, when compared with that in the general population, was reduced in all conditions (19) (20) (21) .
To optimize treatment and care for XY females, broader knowledge of both long-term health outcomes and socioeconomics is essential. Thus, the aim of this study was to examine morbidity, mortality, and socioeconomics (education, cohabitation, motherhood, income, and retirement) in a nationwide cohort of XY females compared with the general population.
Patients and Methods

Setting
Denmark has a uniform public health care system guaranteeing all persons residing in Denmark equal health care access.
The registries
Since 1968, the Danish Civil Registration System has assigned a unique civil personal registration number to all persons residing in Denmark. The civil personal registration number allows accurate matching of data from different data sources.
The Statistics Denmark administers an extensive national collection of data collected from around the 1970s and to the present.
Cases and controls
Previously, we identified all officially registered females with a 46,XY karyotype in the Danish Cytogentic Central Registry and their diagnosis was validated by medical record review or by discharge diagnoses from the Danish National Patient Registry. In total, 124 individuals were verified as XY females of whom 123 are included in the present study. Exact diagnosis, age at diagnosis, and other clinical characteristics are provided in Table 1 (1).
The Division of Research Services at Statistics Denmark identified 12,300 female controls and 12,300 male controls (100 females and 100 males per XY female) from the general population matched on age (month and year of birth) ( Table 1 ). All controls were alive on the date of the DSD diagnosis.
Data
Data concerning morbidity (dates of admission and discharge, primary and secondary diagnoses for all inpatient and outpatient contacts), medical prescriptions (date of processing and Anatomical Therapeutic Chemical Classification System code) mortality (date and cause of death), socioeconomic parameters (education, income, retirement owing to sickness or age, cohabitation and children, including adopted children) and dates of emigration were retrieved for all XY females and controls, if relevant (for further details, see the Supplemental Material and Methods).
Statistical analyses
Morbidity, medical prescriptions, mortality, education, retirement, cohabitation, and motherhood were analyzed by using stratified Cox regression. Each XY female and her controls constituted one stratum.
For morbidity, mortality, and medical prescriptions, follow-up started at birth and ended at (1) first date of any hospital admission regardless of diagnosis (overall morbidity); (2) first date of admission with a certain diagnosis (cause-specific morbidity); (3) death (overall mortality); (4) first date of any prescription (overall prescriptions); (5) first date of a specific prescription (cause-specific prescriptions); or (6) first date of emigration, death, or last date of registration, whichever came first.
For education, retirement, cohabitation, and motherhood, follow-up started at the 18th birthday (education, retirement, and cohabitation), the 15th birthday (motherhood), or the start of registration of the event. Follow-up ended at the first occurrence of the event, such as date of first cohabitation, first date of emigration, death, or last date of registration, whichever came first.
Income was analyzed by using conditional logistic regression, with each XY female and her controls constituting one stratum. Retired persons were excluded from the first year of retirement. The median annual income for controls was computed in 5-year intervals, and for each calendar year, a dichotomous variable indicated whether the income for an XY female was higher or lower than the median income in her respective controls in the 5-year interval. The standard error reported is a robust standard error estimate. All comparisons were to female controls unless clearly stated otherwise.
Age at specific events was compared by using the KruskalWallis test. All analyses were performed for the combined cohort of XY females; some were performed with stratification by AIS and GD or by Prader stage (Prader stage 0 and Prader stage $ 1). Subgroups of XY females were compared by using the x 2 test. Ninety-five percent confidence intervals (CIs) were calculated. P values , 0.05 were considered to indicate statistically significant differences. All analyses were performed by using Stata software, version 14.1 (Stata Corp., College Station, TX).
Ethics
The study was approved by the Danish Data Protection Agency (journal number: 2012-41-0047) and the Danish Health Authorities (journal number: 3-3013-472/1/). All data were accessed via a remote desktop access to Statistics. The civil personal registration number of both cases and controls was anonymized by Statistics Denmark.
Results
Overall morbidity
Overall morbidity was increased in XY females as compared with female controls [hazard ratio (HR), 1.72; 95% CI, 1.43 to 2.08] and male controls (HR, 1.82; 95% CI, 1.51 to 2.19) (Fig. 1A) . After stratification by the DSD diagnosis, the overall morbidity was increased for both AIS (HR, 1.62; 95% CI, 1.29 to 2.05) and GD (HR, 1.97; 95% CI, 1.27 to 3.05) when compared with female controls ( Table 2 ).
All the following comparisons are made to female controls. Median age at first registered hospital admission was The overall morbidity analysis was repeated with the exclusion of the following diagnostic groups: endocrine, gastrointestinal, and urogenital conditions; congenital malformations; and conditions related to pregnancy and birth. With this approach, no difference in morbidity was observed between XY females and controls (HR, 1.13; 95% CI, 0.93 to 1.37) (Fig. 1B) , which applied to both AIS (HR, 1.12; 95% CI, 0.87 to 1.43) and GD (HR, 1.19; 95% CI, 0.74 to 1.90) ( Table 2) .
Cause-specific morbidity XY females had increased morbidity according to the following diagnostic groups: congenital malformations; endocrine and gastrointestinal conditions; and external conditions, including fractures. In contrast, morbidity related to pregnancy and birth was reduced. No difference was observed for the remaining diagnostic groups (Fig. 1B) . Morbidity according to specific diagnostic groups or specific diagnoses is listed in Table 3 .
Neoplasms
Overall, cancer was not increased in XY females, whereas the risk for gonadal cancer (coded as ovarian cancer in the ICD system) was. Gonadal cancer was observed only in those with GD (n = 2). Three XY females (GD: n = 1; unclassified XY female: n = 2) had a benign gonadal neoplasm (coded as benign ovarian neoplasia). Combined, gonadal neoplasia was observed in 12% (3 of 25) of females with GD. No XY females had a diagnosis of breast cancer.
Endocrine disorders
No difference was observed for type 1 and type 2 diabetes in XY females and controls, nor for thyroid disorders. Pituitary disorders (hypopituitarism and hyperprolactinemia) were increased in XY females.
Mental disorders
Adjustment disorders and encopresis were increased in XY females, whereas no difference of depression and other mood disorders was observed.
Circulatory system
Deep venous thrombosis was increased in XY females, and pulmonary embolism was increased with borderline significance. Median age for these diagnoses was 39.9 years (range, 22.2 to 57.2 years). Cerebrovascular diseases, hypertension, heart diseases, and arteriosclerosis were similar in XY females and controls.
Gastrointestinal disorders
Inguinal hernia, predominantly seen in females with AIS, was increased in XY females.
Urogenital system disorders
Primary amenorrhea and hypertrophy of the breast were increased in XY females.
Connective tissue and bone disorders
There was no difference of osteoporosis between XY females and controls.
Congenital malformations
Malformations of the circulatory system, the musculoskeletal system, and the genitalia and gonads were increased among XY females (see Supplemental Material for further details).
External diseases
Fractures were increased in XY females. After stratification on diagnosis, fractures were increased in females with AIS (HR, 2.15; 95% CI, 1.53 to 3.02) but not in those with GD (HR, 1.30; 95% CI, 0.61 to 2.74).
Mortality
Overall mortality was similar in XY females and controls (HR, 0.79; 95% CI, 0.35 to 1.77) ( Table 2) . Median age at death was 71.6 years (range, 0.0 to 91.5 years) in XY females and 76.1 years (range, 1.3 to 102.3 years) in controls.
Six XY females died (GD: n = 1; AIS: n = 1; unclassified XY females: n = 4). The causes of death were as follows; GD: malignant neoplasm of the stomach (ICD-10 code: C16.9); AIS: stroke (ICD-10 code: I64.9); unclassified XY females: (1) acute pancreatitis (ICD-8 code: 5770) and chronic pyelonephritis (ICD-8 code: 5900); (2) malignant neoplasm of the kidney (ICD-8 code: 189.0) and cardiac arrest (ICD-8 code: 472.2); (3) coarctation of the aorta (ICD-8 code: 7471); and (4) pneumonia (ICD-10 code: J18.9) and atherosclerotic heart disease (ICD-10 code: I25.1).
Medical prescriptions
Overall, medical prescriptions were not increased among XY females compared to controls (HR, 1.09; 95% CI, 0.90 to 1.32), a finding that applied to both AIS (HR, 1.18; 95% CI, 0.93 to 1.50) and GD (HR, 1.09; 95% CI, 0.71 to 1.66) ( Table 2 ). Sex hormone prescriptions and urogenital system precriptions were increased, whereas cardiovascular and Table 4 .
Socioeconomics
Cohabitation
Cohabitation was reduced in XY females (HR, 0.44; 95% CI, 0.33 to 0.58) (Fig. 2A) , and it was reduced in both those with AIS (HR, 0.41; 95% CI, 0.29 to 0.59) and those with GD (HR, 0.51; 95% CI, 0.29 to 0.88) ( 
Motherhood
Motherhood was reduced in XY females (HR, 0.10; 95% CI, 0.05 to 0.18) (Fig. 2B) , and this applied to both AIS and GD (Table 2) .
Education
XY females and controls had the same level of education (HR, 0.92; 95% CI, 0.61 to 1.37) (Fig. 2C) , which applied to both AIS (HR, 0.90; 95% CI, 0.55 to 1.47) and Income XY females' income differed from the median income in controls. As such, XY females had a lower income from 20 to 29 years of age, a similar income from 30 to 49 years of age, and a higher income from 50 to 59 years of age (Fig. 2D) .
Retirement
Retirement was similar in XY females and controls (HR, 0.76; 95% CI, 0.37 to 1.55). After stratification by diagnosis, there was no difference between females with AIS and controls (HR, 1.07; 95% CI, 0.41 to 2.80). No retirements were observed for GD ( Table 2 
Discussion
This study comparing XY females with the general population shows that XY females have an increased overall morbidity, but not mortality, related to their specific condition. In terms of socioeconomic factors, XY females fared similarly to controls concerning education, income, and retirement, whereas both cohabitation and motherhood were reduced in XY females. Overall, XY females with AIS and GD had a similar trajectory of health and socioeconomic factors.
Overall morbidity was increased in XY females, when observing any first hospital admission. As expected, XY females had an increased morbidity related to the diagnostic groups of congenital malformations and endocrine and gastrointestinal conditions because these encompass the diagnoses of the DSD condition itself [e.g., AIS and CAH (endocrine conditions)], diagnoses associated to the cause of being diagnosed with DSD [inguinal hernia (gastointestinal conditions)], or diagnoses of malformations related to genitalia and gonads. Primary amenorrhea, another likely cause of DSD diagnosis, is included in the diagnostic group of urogenital conditions, and XY females had an increased incidence of primary amenorrhea; however, the overall urogenital morbidity was not increased. As expected, morbidity related to pregnancy and birth was reduced. When we estimated morbidity after excluding the above-mentioned diagnostic groups, no difference between XY females and controls was observed. This observation was substantiated by the similarity in overall medical prescriptions comparing XY females and controls.
Gonadal malignancy was increased in XY females with GD (Table 3) . After pooling of XY females with GD, who were registered as having benign gonadal tumors or gonadal cancer, the total prevalence of gonadal tumors was 12%. As such, the prevalence of gonadal tumors in GD in this study is within the range of previous estimates (10% to 60%). Concerning CAIS, consensus today is to postpone gonadectomy until after puberty if the AR mutation is known (22) , and sometimes even beyond that. Thus, evidence of the safety of postponing gonadectomy is requested. In the current study, no XY female with AIS was diagnosed with a gonadal tumor. However, 92% of females with AIS included in the study had undergone gonadectomy at a median age of 8.3 years (Table 1) (1). We have no data on the gonadal histology in patients with AIS or GD; thus, this study cannot provide valid data on the risk for gonadal tumors in XY females.
Overall, XY females had no increased occurrence of circulatory system diseases, particularly not of ischemic heart disease, arteriosclerosis, hypertension, and cerebrovascular disease. Furthermore, a reduced occurrence of prescriptions related to cardiovascular disease was observed. This observation substantiates that the cardiovascular status in the present cohort of XY females at the end of follow-up was unaffected by the DSD even though severe estrogen deficiency due to nonadherence to treatment or due to periods with loss to medical follow-up could have led to an increased occurrence of cardiovascular events. Type 2 diabetes was also not increased in XY females. However, XY females were comparatively young at the end of follow-up (median age, 32.5 years; range, 0.0 to 91.5 years); thus, the deleterious effects of estrogen deficiency may not yet have appeared. In contrast, we observed an increased occurrence of DVT and pulmonary embolism with borderline significance. This could be due to hormone treatment. Only one of seven women registered with venous thromboembolism was treated with oral contraceptives which, at least in perimenopausal or postmenopausal women, seem to carry a higher risk for venous thromboembolism than does estradiol treatment alone (23) . Concerning sex hormone treatment, it was surprising that 16 XY females with AIS received treatment with a combination of estrogen and progesterone.
Fractures were increased among XY females. This is considered to be associated with reduced bone health, although occurrence of osteoporosis or prescriptions of bisphosphonates did not differ from controls. Previously, bone mineral density was reported as being lower in XY females with GD than in XY females with CAIS (14) . We, on the other hand, observed an increased occurrence of fractures in AIS only. However, this may be due to lack of statistical power in the GD subgroup.
No difference was observed for the occurrence of type 1 diabetes or thyroid disorders, both of which are common in, for example, Turner syndrome (18) . However, the occurrence of hypopituitarism was increased. We speculate whether this is due to misdiagnosis of hypergonadotropic hypogonadism, even though it has been suggested that long-standing hypogonadism may lead to compensatory development of a gonadotrophic pituitary adenoma (24) . In case of hypopituitarism, hormones are prescribed by the hospital pharmacy; thus, the MSR does not hold this information and, therefore, we were unable to validate the diagnosis of hypopituitarism by hormone prescriptions registered in the MSR.
Outcomes of studies concerning quality of life in DSD have been equivocal, ranging from reduced quality of life to similar or even better quality of life than among controls (25) (26) (27) . Generally, virilized XY females have inferior outcomes compared with nonvirilized XY females. In the current study, the occurrence of diagnosed depressions and the occurrence of prescribed antidepressives did not differ between XY females and controls. However, significantly more virilized XY females had prescriptions for antidepressives than did nonvirilized XY females, supporting the reports of reduced psychological well-being due to virilization.
XY females were less likely to cohabitate than controls, and cohabitation occurred later in life, regardless of diagnosis (AIS or GD) and Prader stage. This may be due to a negative effect of the DSD condition on self-esteem and person's expectations. We find this substantiated by the increased occurrence of adjustment disorders among XY females. Other studies have likewise reported XY females being less likely to engage in relationships (28, 29) , although Hines et al. (30) found the prevalence of relationships similar in CAIS and controls. We speculate whether receiving a DSD diagnosis influences the likelihood of cohabitating, thus leading to impairment of cohabitation after but not before the DSD diagnosis. In the current study, however, 75% of patients were diagnosed by the age of 18 years, i.e., before the time in life when cohabitation normally takes place. XY females with a uterus can achieve motherhood through oocyte donation (31) . Nevertheless, motherhood was rare among XY females, although our data included XY females who became mothers to adopted children.
Education was similar in XY females and controls. Concerning income, XY females had a higher income than the median income in controls from an age around the mid-40s and onward, suggesting that XY females generally perform well on the labor market. This is in line with an Italian study reporting more XY females with a university degree than in the general Italian population (28) . A German study reported approximately 65% (n = 8/12) of nonvirilized XY females with a high to very high educational level (26) . We have no obvious explanations for the reduced income in XY females in the younger age groups in the current study, but previously we observed a similar pattern in Turner syndrome (21) . We speculate whether XY females are more unsure of themselves in their younger years and whether this leads to increased parental support, including financial support. Thus, the need to have a job and earn money may be lower in XY females than in the general population.
The strength of the current study is the nationwide approach, which minimizes selection bias; such bias is often present in studies requiring active participation. Furthermore, the close matching with controls enables a strong comparison with the general population. The complete follow-up allows accounting for changes in specific outcomes over time. Limitations are the risk for misclassification, applicable to all epidemiologic studies, and the lack of a specific diagnosis in 15 XY females.
In conclusion, XY females have an overall morbidity similar to that of the female background population in terms of diagnoses unrelated to the DSD condition per se. In contrast, the DSD condition seems to reduce the likelihood of both cohabitating and having children, even when adoptions are taken into account. The proportion of XY females who achieved an education was similar to female controls, and on the basis of the income in the older years, XY females seem to perform well in the labor market.
